Screener
Edwards Lifesciences EW Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on the most recent quarter.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's debt-to-equity?
- Edwards Lifesciences (EW) reported debt-to-equity of 0.1× in Q1 2026.
- How has Edwards Lifesciences's debt-to-equity changed year-over-year?
- Edwards Lifesciences's debt-to-equity decreased by 1.4% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Edwards Lifesciences's debt-to-equity?
- Over 5 years (2020 to 2025), Edwards Lifesciences's debt-to-equity has grown at a -14.8% compound annual growth rate (CAGR), from 0.2× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Edwards Lifesciences's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude